Patents by Inventor Robert E. Atkinson

Robert E. Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190090890
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Application
    Filed: November 27, 2018
    Publication date: March 28, 2019
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, MATTHEW J. OLSON, ROBERT E. ATKINSON
  • Publication number: 20190059927
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Applicant: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 10166035
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 1, 2019
    Assignee: BRIDGEPOINT MEDICAL, INC.
    Inventors: Chad J. Kugler, Matthew J. Olson, Robert E. Atkinson
  • Patent number: 10143487
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: December 4, 2018
    Assignee: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 10105538
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: October 23, 2018
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Publication number: 20180200512
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Applicant: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
  • Publication number: 20180078761
    Abstract: A method including chronically implanting a nerve cuff electrode on a portion of a hypoglossal nerve, chronically implanting a respiration sensing lead subcutaneously in a thorax of a patient, the respiration sensing lead having a plurality of bio-impedance electrodes defining at least one bio-impedance vector. The method may also include sensing a bio-impedance signal corresponding to respiration via a bio-impedance vector on an anterior side of the thorax, analyzing the bio-impedance signal to identify onsets of expiration, predicting an onset of a future expiratory phase, and delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the bio-impedance signal; wherein stimulus delivery is initiated before the onset of the future expiratory phase and continued during an entire inspiratory phase, and wherein the method is performed without identifying an onset of an inspiratory phase.
    Type: Application
    Filed: July 31, 2017
    Publication date: March 22, 2018
    Applicant: CYBERONICS, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Patent number: 9913982
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: March 13, 2018
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
  • Patent number: 9877825
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: January 30, 2018
    Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
  • Publication number: 20180014928
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Application
    Filed: May 10, 2017
    Publication date: January 18, 2018
    Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
  • Publication number: 20180008824
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Application
    Filed: August 25, 2017
    Publication date: January 11, 2018
    Applicant: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
  • Publication number: 20180000513
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 4, 2018
    Applicant: BridgePoint Medical, Inc.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON, MATTHEW J. OLSON
  • Publication number: 20170319332
    Abstract: Intraocular lenses (IOLs) that improve lens stability by, for example, increasing anterior-posterior stiffness of the IOL, increasing anterior-posterior dimensions of the IOL and/or increasing contact area with the equator of the bag to resist movement of the IOL as the bag collapses over time. These IOLs may be non-modular (single component) or modular (multiple component). In modular embodiments, the IOL system may include intraocular base and optic components, which, when combined, form a modular IOL.
    Type: Application
    Filed: May 3, 2017
    Publication date: November 9, 2017
    Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. KAHOOK, Glenn SUSSMAN, Rudolph F. ZACHER, Paul J. McLEAN, Robert E. ATKINSON
  • Patent number: 9788855
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: October 17, 2017
    Assignee: BridgePoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Patent number: 9744354
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Grant
    Filed: December 30, 2009
    Date of Patent: August 29, 2017
    Assignee: CYBERONICS, INC.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
  • Patent number: 9681946
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: June 20, 2017
    Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
  • Publication number: 20160375232
    Abstract: Devices and methods for less invasively treating the gastrointestinal system, such as the intestinal mucosa of the small bowel. Embodiments described herein may be used to reduce caloric absorption and effectuate weight loss, for example.
    Type: Application
    Filed: September 9, 2016
    Publication date: December 29, 2016
    Inventors: Chad J. KUGLER, Robert E. ATKINSON
  • Publication number: 20160278912
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Application
    Filed: June 8, 2016
    Publication date: September 29, 2016
    Applicants: The Regents of the University of Colorado, a body corporate, ClarVista Medical, Inc.
    Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Paul MCLEAN, Robert E. ATKINSON
  • Publication number: 20160235587
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 18, 2016
    Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
  • Patent number: 9387069
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: July 12, 2016
    Assignees: ClarViata Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson